Aditya Bardia
MD, MPH
Director, Translational Research Integration
👥Biography 个人简介
Aditya Bardia was a principal investigator for sacituzumab govitecan in triple negative and hormone receptor-positive metastatic breast cancer through the ASCENT and TROPiCS-02 trials. His work established TROP2-directed antibody drug conjugates as a new therapeutic class. He leads translational breast cancer programs at UCLA.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Aditya Bardia 的研究动态
Follow Aditya Bardia's research updates
留下邮箱，当我们发布与 Aditya Bardia（UCLA Jonsson Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment